Last reviewed · How we verify

NCT04968314: ChiPP2

ChiPP2: A Trauma-Informed Program for City School Parents

Completed Last updated 25 June 2024
What this trial tests

trial testing Chicago Parent Program in Parenting in 244 participants. Completed in 17 June 2024.

Timeline
28 February 2020
Primary endpoint
30 April 2024
17 June 2024

Quick facts

Lead sponsorJohns Hopkins University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment244
Start date28 February 2020
Primary completion30 April 2024
Estimated completion17 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Johns Hopkins University

Who can join

Adults 18 to 99, any sex, with Parenting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose of this study is to assess the prevalence of adverse childhood experiences (ACEs) and positive childhood experiences (PCEs) among parents enrolled in the Chicago Parent Program (ChiPP) in their child's school and whether those experiences are associated with a) parents' participation in ChiPP and b) program benefits for parents and children.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Understanding the role of parents' social connectedness in children's behavioral wellbeing in low-income communities: A study protocol.
    Plesko CM, Tobin K, Gross D. · · 2023 · cited 1× · PMID 36453185 · DOI 10.1002/nur.22281

Verify or expand the search:

Other trials of Chicago Parent Program

Trials testing the same drug.

Other recruiting trials for Parenting

Currently open trials in the same condition.

Other Johns Hopkins University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04968314.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing